The Effects of PaCO2 Levels on Cerebral Metabolism and Perfusion During Induced Hypothermia.
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Incidence of hypo- and hypercarbia during induced hypothermia after cardiac arrest is high. The original report from HACA-group reported that hypothermia treated patients had improved survival and neurological outcome. Suprisingly, in that trial normocarbia was not achieved even though the aim was set for ventilatory support as normoventilation. This study aims to investigate the effects of mild hypo- and hypercarbia on cerebral perfusion (blood flow, intracranial pressure) and metabolism (microdialysate metabolites). We hypothesize that uncontrolled ventilatory suppport may render the patients in risk of exacerbation of neuronal damage, conversely, further improvement in outcome may be achieved with succesfull ventilatory management. We intend to enroll 10 out-of-hospital cardiac arrest patients succesfully resuscitated and subsequently treated with controlled hypothermia for 24 hours. The patients in need of anticoagulation are excluded. We plan to induce mild hypocarbia and hypercarbia during and after induced hypothermia. Metabolic and perfusion data are collected with clinically used methods such as transcranial doppler, intracranial pressure measurement, near infrared spectroscopy, jugular bulb, intracerebral microdialysis).
| Condition | Intervention |
|---|---|
|
Cerebral Metabolism and Perfusion |
Other: mild hypo- and hyperventilation |
| Study Type: | Interventional |
| Official Title: | The Effects of PaCO2 Levels on Cerebral Metabolism and Perfusion During Induced Hypothermia. |
- surrogate physiological endpoints
| Arms | Assigned Interventions |
|---|---|
| crossover: hypo- and hypercarbia |
Other: mild hypo- and hyperventilation
induction of mild hypo- and hypercarbia
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
succesfull resuscitation of out of hospital cardiac arrest, primary rhytm shockable
Exclusion Criteria:
- known coagulopathy, need of anticoagulation therapy, need of interventional cardiological procedures
Contacts and Locations| Contact: Jyrki J Tenhunen, MD, PhD | +358500677195 | jyrki.tenhunen@pshp.fi |
| Contact: Patrik RH Falkenbach, MD | +358405604636 | patrik.falkenbach@pshp.fi |
| Finland | |
| Critical Care Medicine Research Group/ department of intensive care | Recruiting |
| Tampere, Pirkanmaa, Finland, 33521 | |
| Contact: Jyrki J Tenhunen, MD, PhD +358500677195 jyrki.tenhunen@pshp.fi | |
| Contact: Patrik RH Falkenbach, MD +358405604636 patrik.falkenbach@pshp.fi | |
| Sub-Investigator: Patrik RH Falkenbach, MD | |
| Principal Investigator: Jyrki J Tenhunen, MD, PhD | |
| Sub-Investigator: Antti Kämäräinen, MD | |
More Information
Additional Information:
No publications provided
| Responsible Party: | Critical Care Medicine Research Group, Tampere University Hospital |
| ClinicalTrials.gov Identifier: | NCT00766103 History of Changes |
| Other Study ID Numbers: | R06213 |
| Study First Received: | October 2, 2008 |
| Last Updated: | October 2, 2008 |
| Health Authority: | Finland: Ministry of health |
Keywords provided by Tampere University Hospital:
|
Cerebral metabolism, perfusion, induced hypothermia |
Additional relevant MeSH terms:
|
Hypothermia Body Temperature Changes Signs and Symptoms |
ClinicalTrials.gov processed this record on May 16, 2013